Lead Product(s): Dialkylcarbamoylchloride
Therapeutic Area: Trauma (Emergency, Injury, Surgery)
Highest Development Status: Approved Product Type: Small molecule
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition February 27, 2020
ABIGO Medical has leading innovations in advanced wound care that reduce the spread of bacteria without increasing resistance to antibiotics.